Olympus opens new operational headquarters

Friday, 11 April, 2014

Olympus Australia has moved its operational headquarters to a state-of-the-art facility in Melbourne that incorporates a fully operational customer experience centre, comprehensive training facilities and the company’s national service centre.

The headquarters building for Olympus in Australia and New Zealand.

Olympus is a manufacturer and distributor of optical, electronic and precision engineering products for scientific, medical and industrial applications. Customers visiting the facility will be able to experience the complete range of these products in the various rooms dedicated to each of the company’s portfolios.

Industrial business division customers will have hands-on access to products utilised in non-destructive testing, remote visual inspection, materials analysis by X-ray fluorescence and high-speed imaging. Similar demonstration and training areas are available to digital photography and microscopy customers.

Visitors in the fully equipped endoscopy room of the Olympus customer experience centre.

For medical imaging customers, the building has multiple training rooms, including a fully equipped operating theatre and an endoscopy room. All the medical systems are integrated utilising the latest control software which allows direct and remote control and monitoring of any piece of equipment.

On the floor below the customer experience centre is the national service centre, where cleanroom conditions have been established to disinfect, assess, repair and quality control the maintenance and upgrading of all instruments, including medical imaging equipment such as endoscopes and other medical devices.

Inside the national service centre.

Les Dick, CEO of the Australian Institute for Non-Destructive Testing (AINDT), described the building as “stunning”.

“In the past, AINDT has collaborated with Olympus to present specialised training seminars,” he noted, “and we look forward to bringing our members to this new facility and allowing them to gain hands-on experience of the latest technology.”

Related News

Vaxxas to advance its microarray patches for COVID vaccination

Vaxxas will receive AU$3.2m from BARDA to accelerate work advancing its high-density microarray...

Global competition targets 'undruggable' cancer protein

A new global competition offering over US$500,000 in prizes aims to spur drug discovery...

SMi Systems appoints Dr Ankur Mutreja as Senior Advisor

Mutreja was previously Head of Global South Partnerships at CEPI, where he was responsible for...


  • All content Copyright © 2025 Westwick-Farrow Pty Ltd